{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:13:31Z","timestamp":1789647211040,"version":"4.0.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T00:00:00Z","timestamp":1613952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Gut Pathog"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The aim of this study was to determine the dominant species of bacteria found in blood cultures collected from patients under treatment in the tertiary inflammatory bowel disease (IBD) center in Poland. The dominant pathogen isolated from blood in patients with IBD was <jats:italic>Staphylococcus epidermidis<\/jats:italic> MRCNS (MRCNS\u2014methicillin-resistant coagulase-negative <jats:italic>Staphylococcus<\/jats:italic>), a strain resistant to all beta-lactam antibiotics (penicillins, penicillins with B-lactamase inhibitor, cephalosporins and carbapenems). The second most commonly isolated pathogen found in the blood samples was <jats:italic>Escherichia coli<\/jats:italic>. Blood cultures were found to be positive for these pathogens more frequently in male patients (90.0%). An increased risk of bacteremia in IBD patients was associated with prolonged hospitalization.<\/jats:p>","DOI":"10.1186\/s13099-021-00408-6","type":"journal-article","created":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T14:06:51Z","timestamp":1614002811000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Are hospitalized patients with inflammatory bowel disease at increased risk of invasive bacterial infections? Results from POLIBD 3-year cohort study"],"prefix":"10.1186","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1390-9278","authenticated-orcid":false,"given":"Jolanta","family":"Gruszecka","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafa\u0142","family":"Filip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,2,22]]},"reference":[{"key":"408_CR1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2017.02.028","author":"CW Teshima","year":"2017","unstructured":"Teshima CW, Goodman KJ, El-Kalla M, et al. Increased intestinal permeability in relatives of patients with Crohn\u2019s disease is not associated with small bowel ulcerations. ClinGastroenterolHepatol. 2017. https:\/\/doi.org\/10.1016\/j.cgh.2017.02.028.","journal-title":"ClinGastroenterolHepatol"},{"key":"408_CR2","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1186\/s12879-017-2233-z","volume":"7","author":"KO Gradel","year":"2017","unstructured":"Gradel KO, Jensen US, Schonheyder HC, et al. Impact of appropriate empirical antibiotic treatment on recurrence and mortality in patients with bacteraemia: a population-based cohort study. BMC Infect Dis. 2017;7:122.","journal-title":"BMC Infect Dis"},{"key":"408_CR3","doi-asserted-by":"publisher","first-page":"1409","DOI":"10.1038\/ajg.2012.218","volume":"107","author":"GR Lichtenstein","year":"2012","unstructured":"Lichtenstein GR, Feagan BG, Cohen RD, et al. Serious infection and mortality in patients with Crohn\u2019s disease: more than 5 years of follow-up in the TREAT registry. Am J Gastroenterol. 2012;107:1409.","journal-title":"Am J Gastroenterol"},{"key":"408_CR4","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1053\/j.gastro.2018.04.012","volume":"155","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018;155:337.","journal-title":"Gastroenterology"},{"key":"408_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/s10096-015-2373-2","author":"L Coorevits","year":"2015","unstructured":"Coorevits L, Van den Abeele AM. Evaluation of the BD BACTEC FX blood volume monitoring system as a continuous quality improvement measure. Eur J Clin Microbiol Infect Dis. 2015. https:\/\/doi.org\/10.1007\/s10096-015-2373-2.","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"408_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/PAT.0b013e328358343c","volume":"44","author":"P Harris","year":"2012","unstructured":"Harris P, Vinney J, Ashhurst-Smith Ch, et al. Comparison of Vitek MS (MALDI-TOF) to standard routine Identification methods: an advance but no panacea. Pathology. 2012;44:1\u20133.","journal-title":"Pathology."},{"key":"408_CR7","doi-asserted-by":"publisher","DOI":"10.1177\/2050640619874524","author":"I Goren","year":"2020","unstructured":"Goren I, Brom A, Yanai H, et al. Risk of bacteremia in hospitalised patients with inflammatory bowel disease: a 9-year cohort study. United EurGastroenterol J. 2020. https:\/\/doi.org\/10.1177\/2050640619874524.","journal-title":"United EurGastroenterol J"},{"issue":"7","key":"408_CR8","first-page":"B5128","volume":"62","author":"SL Nielsen","year":"2015","unstructured":"Nielsen SL. The incidence and prognosis of patients with bacteremia. Dan Med J. 2015;62(7):B5128.","journal-title":"Dan Med J."},{"key":"408_CR9","doi-asserted-by":"publisher","DOI":"10.1053\/j.gastro.2018.04.012","author":"J Kirchgesner","year":"2018","unstructured":"Kirchgesner J, Lemaitre M, Carrat F, et al. Risk of serious and opportunistic infections associated with treatment of inflammatory bowel diseases. Gastroenterology. 2018. https:\/\/doi.org\/10.1053\/j.gastro.2018.04.012.","journal-title":"Gastroenterology."},{"key":"408_CR10","doi-asserted-by":"publisher","unstructured":"Hashash JG, Chintamaneni P, Rivers RCM, et al. Patterns of antibiotic exposure and clinical disease activity in inflammatory bowel disease: a 4-year prospective study. Inflamm Bowel Dis. 2015; https:\/\/doi.org\/10.1097\/MIB.0000000000000534","DOI":"10.1097\/MIB.0000000000000534"}],"container-title":["Gut Pathogens"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13099-021-00408-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13099-021-00408-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,22]],"date-time":"2021-02-22T14:11:13Z","timestamp":1614003073000},"score":1,"resource":{"primary":{"URL":"https:\/\/gutpathogens.biomedcentral.com\/articles\/10.1186\/s13099-021-00408-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,2,22]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["408"],"URL":"https:\/\/doi.org\/10.1186\/s13099-021-00408-6","relation":{},"ISSN":["1757-4749"],"issn-type":[{"value":"1757-4749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,2,22]]},"assertion":[{"value":"7 November 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 February 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 February 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study was approved by the Bioethics Committee of the Regional Medical Chamber (Resolution No. 88\/B\/2020 of September 24, 2020). As only retrospective studies were performed, according to Polish law patient consent was not required.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All authors declare no conflicts of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"12"}}